lacticaseibacillus rhamnosus r0011
PolandDrugs containing this active substance
-
The medicine is a probiotic used to prevent intestinal microflora disturbances during and after antibiotic therapy, as well as to prevent traveler's diarrhea. It is also used as an adjunct treatment during antibiotic therapy and in cases of recurrent pseudomembranous colitis.
Form: capsules, hard
Active substance Dosage lacticaseibacillus rhamnosus r0011 10^9 CFU lactobacillus helveticus r0052 10^9 CFU ATC: A07FA
Manufacturer: Creapharm Industry Lallemand S.A.